Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 9
Submit an article Journal homepage
222
Views
23
CrossRef citations to date
0
Altmetric
Review

CD8 T cells and latent herpes simplex virus type 1: keeping the peace in sensory ganglia

Brian S Sheridan University of Pittsburgh, School of Medicine, Graduate Program in Immunology, 203 Lothrop Street, Pittsburgh, PA, 15213, USA; University of Pittsburgh, School of Medicine, Department of Ophthalmology, 203 Lothrop Street, Pittsburgh, PA, 15213, USA
,
Jared E Knickelbein University of Pittsburgh, School of Medicine, Graduate Program in Immunology, 203 Lothrop Street, Pittsburgh, PA, 15213, USA; University of Pittsburgh, School of Medicine, Department of Ophthalmology, 203 Lothrop Street, Pittsburgh, PA, 15213, USA
&
Robert L Hendricks University of Pittsburgh, School of Medicine, Department of Immunology, Director Ophthalmology and Visual Sciences Research Center, Eye and Ear Institute, Rm. 922, 203 Lothrop Street, Pittsburgh, PA, 15213, USA +412 647 5754; +412 647 5880; [email protected]; University of Pittsburgh, School of Medicine, Department of Ophthalmology, 203 Lothrop Street, Pittsburgh, PA, 15213, USA; University of Pittsburgh, School of Medicine, Department of Molecular Genetics and Biochemistry, 203 Lothrop Street, Pittsburgh, PA, 15213, USA
Pages 1323-1331 | Published online: 29 Aug 2007

Bibliography

  • ROIZMAN B, KNIPE DM: Herpes simplex viruses and their replication. In: Fields Virology. Fields BN (Ed.), Lippincott-Raven, Philadelphia, USA (2001):2399-2459.
  • PEPOSE JS, KEADLE TL, MORRISON LA: Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am. J. Ophthalmol. (2006) 141:547-557.
  • LIESEGANG TJ: Epidemiology of ocular herpes simplex. Natural history in Rochester, MN 1950 through 1982. Arch. Ophthalmol. (1989) 107:1160-1165.
  • LIESEGANG TJ, MELTON LJ, DALY PJ, ILSTRUP DM: Epidemiology of ocular herpes simplex. Incidence in Rochester, MN, 1950 through 1982. Arch. Ophthalmol. (1989) 107:1155-1159.
  • LABETOULLE M, AUQUIER P, CONRAD H et al.: Incidence of herpes simplex virus keratitis in France. Ophthalmology (2005) 112:888-895.
  • PAVAN-LANGSTON D: Herpes Simplex of the Ocular Anterior Segment. Blackwell Science, Inc., Malden, MA, USA (2000).
  • GORBACH S, BARTLETT J, BLACKLOW N: Infectious Diseases. Gorbach S (Ed.), Saunders, Philadelphia, USA (1998).
  • LIEDTKE W, OPALKA B, ZIMMERMANN CW, LIGNITZ E: Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J. Neurol. Sci. (1993) 116:6-11.
  • WHITLEY R, LAKEMAN AD, NAHMIAS A, ROIZMAN B: DNA restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N. Engl. J. Med. (1982) 307:1060-1062.
  • WHITLEY RJ: Herpes simplex encephalitis: adolescents and adults. Antiviral Res. (2006) 71:141-148.
  • COSAR CB, SRIDHAR MS, COHEN EJ et al.: Indications for penetrating keratoplasty and associated procedures, 1996 – 2000. Cornea (2002) 21:148-151.
  • JACKSON SA, DELUCA NA: Relationship of herpes simplex virus genome configuration to productive and persistent infections. Proc. Natl. Acad. Sci. USA (2003) 100:7871-7876.
  • MAUL GG, GULDNER HH, SPIVACK JG: Modification of discrete nuclear domains induced by herpes simplex virus Type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. (1993) 74(Part 12):2679-2690.
  • DECMAN V, KINCHINGTON PR, HARVEY SA, HENDRICKS RL: γ interferon can block herpes simplex virus Type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. (2005) 79:10339-10347.
  • STEINER I, SPIVACK JG, O'BOYLE DR, LAVI E, FRASER NW: Latent herpes simplex virus Type 1 transcription in human trigeminal ganglia. J. Virol. (1988) 62:3493-3496.
  • STEVENS JG, WAGNER EK, DEVI-RAO GB, COOK ML, FELDMAN LT: RNA complementary to a herpesvirus α gene mRNA is prominent in latently infected neurons. Science (1987) 235:1056-1059.
  • JAVIER RT, STEVENS JG, DISSETTE VB, WAGNER EK: A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology (1988) 166:254-257.
  • SEDARATI F, IZUMI KM, WAGNER EK, STEVENS JG: Herpes simplex virus Type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons. J. Virol. (1989) 63:4455-4458.
  • COOK SD, PAVELOFF MJ, DOUCET JJ, COTTINGHAM AJ, SEDARATI F, HILL JM: Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest. Ophthalmol. Vis. Sci. (1991) 32:1558-1561.
  • MARGOLIS TP, IMAI Y, YANG L, VALLAS V, KRAUSE PR: HSV-2 establishes latent infection in a different population of ganglionic neurons than HSV-1: role of LAT. J. Virol. (2006).
  • PERNG GC, JONES C, CIACCI-ZANELLA J et al.: Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science (2000) 287:1500-1503.
  • THOMPSON RL, SAWTELL NM: Herpes simplex virus Type 1 latency-associated transcript gene promotes neuronal survival. J. Virol. (2001) 75:6660-6675.
  • GUPTA A, GARTNER JJ, SETHUPATHY P, HATZIGEORGIOU AG, FRASER NW: Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature (2006) 442:82-85.
  • SAINZ B, LOUTSCH JM, MARQUART ME, HILL JM: Stress-associated immunomodulation and herpes simplex virus infections. Med. Hypotheses (2001) 56:348-356.
  • SAWTELL NM, THOMPSON RL: Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J. Virol. (1992) 66:2150-2156.
  • PADGETT DA, SHERIDAN JF, DORNE J, BERNTSON GG, CANDELORA J, GLASER R: Social stress and the reactivation of latent herpes simplex virus Type 1. Proc. Natl. Acad. Sci. USA (1998) 95:7231-7235.
  • STEVENS JG, COOK ML: Latent herpes simplex virus in spinal ganglia of mice. Science (1971) 173:843-845.
  • KNOTTS FB, COOK ML, STEVENS JG: Latent herpes simplex virus in the central nervous system of rabbits and mice. J. Exp. Med. (1973) 138:740-744.
  • KHANNA KM, BONNEAU RH, KINCHINGTON PR, HENDRICKS RL: Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity (2003) 18:593-603.
  • LIU T, KHANNA KM, CHEN X, FINK DJ, HENDRICKS RL: CD8(+) T cells can block herpes simplex virus Type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. (2000) 191:1459-1466.
  • LIU T, TANG Q, HENDRICKS RL: Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus Type 1 corneal infection. J. Virol. (1996) 70:264-271.
  • SHIMELD C, WHITELAND JL, NICHOLLS SM et al.: Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus Type 1. J. Neuroimmunol. (1995) 61:7-16.
  • CANTIN EM, HINTON DR, CHEN J, OPENSHAW H: γ interferon expression during acute and latent nervous system infection by herpes simplex virus Type 1. J. Virol. (1995) 69:4898-4905.
  • HALFORD WP, GEBHARDT BM, CARR DJ: Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus Type 1. J. Immunol. (1996) 157:3542-3549.
  • CHEN SH, GARBER DA, SCHAFFER PA, KNIPE DM, COEN DM: Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation. Virology (2000) 278:207-216.
  • COOK WJ, KRAMER MF, WALKER RM et al.: Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection. Virol. J. (2004) 1:5.
  • MINAGAWA H, YANAGI Y: Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+T cells: a new model for latency. Arch. Virol. (2000) 145:2259-2272.
  • GHIASI H, PERNG G, NESBURN AB, WECHSLER SL: Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus Type 1 latency in mice. Microb. Pathog. (1999) 27:387-394.
  • GESSER RM, VALYI-NAGY T, FRASER NW: Restricted herpes simplex virus Type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes. Virology (1994) 200:791-795.
  • SIMMONS A, TSCHARKE DC: Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. (1992) 175:1337-1344.
  • SUVAS S, AZKUR AK, ROUSE BT: Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia. J. Immunol. (2006) 176:1703-1711.
  • VAN LINT AL, KLEINERT L, CLARKE SR, STOCK A, HEATH WR, CARBONE FR: Latent infection with herpes simplex virus is associated with ongoing CD8+ T-cell stimulation by parenchymal cells within sensory ganglia. J. Virol. (2005) 79:14843-14851.
  • CROEN KD, OSTROVE JM, DRAGOVIC LJ, SMIALEK JE, STRAUS SE: Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene ‘anti-sense’ transcript by in situ hybridization. N. Engl. J. Med. (1987) 317:1427-1432.
  • STROOP WG, SCHAEFER DC: Herpes simplex virus, Type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization. Acta Neuropathol. (Berl) (1987) 74:124-132.
  • LIU T, KHANNA KM, CARRIERE BN, HENDRICKS RL: γ interferon can prevent herpes simplex virus Type 1 reactivation from latency in sensory neurons. J. Virol. (2001) 75:11178-11184.
  • WOJTASIAK M, JONES CM, SULLIVAN LC, WINTERHALTER AC, CARBONE FR, BROOKS AG: Persistent expression of CD94/NKG2 receptors by virus-specific CD8 T cells is initiated by TCR-mediated signals. Int. Immunol. (2004) 16:1333-1341.
  • MOSER JM, GIBBS J, JENSEN PE, LUKACHER AE: CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat. Immunol. (2002) 3:189-195.
  • HOSHINO Y, PESNICAK L, COHEN JI, STRAUS SE: Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with the viral load and inversely with the number of infiltrating CD8+T cells. J. Virol. (2007) 81:8157-8164.
  • THEIL D, DERFUSS T, PARIPOVIC I et al.: Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. (2003) 163:2179-2184.
  • HUFNER K, DERFUSS T, HERBERGER S et al.: Latency of α-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia. J. Neuropathol. Exp. Neurol. (2006) 65:1022-1030.
  • VERJANS GM, HINTZEN RQ, VAN DUN JM et al.: Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. USA (2007) 104:3496-3501.
  • SALLUSTO F, GEGINAT J, LANZAVECCHIA A: Central memory and effector memory T cell subsets: function, generation, and maintenance. Ann. Rev. Immunol. (2004) 22:745-763.
  • MA A, KOKA R, BURKETT P: Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Ann. Rev. Immunol. (2006) 24:657-679.
  • WHERRY EJ, BARBER DL, KAECH SM, BLATTMAN JN, AHMED R: Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl. Acad. Sci. USA (2004) 101:16004-16009.
  • BARBER DL, WHERRY EJ, MASOPUST D et al.: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2006) 439:682-687.
  • DAY CL, KAUFMANN DE, KIEPIELA P et al.: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006) 443:350-354.
  • RADZIEWICZ H, IBEGBU CC, FERNANDEZ ML et al.: Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. (2007) 81:2545-2553.
  • SHERIDAN BS, KHANNA KM, FRANK GM, HENDRICKS RL: Latent virus influences the generation and maintenance of CD8+ T cell memory. J. Immunol. (2006) 177:8356-8364.
  • POSAVAD CM, KOELLE DM, SHAUGHNESSY MF, COREY L: Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses. Proc. Natl. Acad. Sci. USA (1997) 94:10289-10294.
  • PORTEOUS C, BRADLEY JA, HAMILTON DN, LEDINGHAM IM, CLEMENTS GB, ROBINSON CG: Herpes simplex virus reactivation in surgical patients. Crit. Care Med. (1984) 12:626-628.
  • BLONDEAU JM, AOKI FY, GLAVIN GB: Stress-induced reactivation of latent herpes simplex virus infection in rat lumbar dorsal root ganglia. J. Psychosom. Res. (1993) 37:843-849.
  • BONNEAU RH: Stress-induced effects on integral immune components involved in herpes simplex virus (HSV)-specific memory cytotoxic T lymphocyte activation. Brain Behav. Immunol. (1996) 10:139-163.
  • WONNACOTT KM, BONNEAU RH: The effects of stress on memory cytotoxic T lymphocyte-mediated protection against herpes simplex virus infection at mucosal sites. Brain Behav. Immunol. (2002) 16:104-117.
  • BONNEAU RH, SHERIDAN JF, FENG NG, GLASER R: Stress-induced effects on cell-mediated innate and adaptive memory components of the murine immune response to herpes simplex virus infection. Brain Behav. Immunol. (1991) 5:274-295.
  • FREEMAN ML, SHERIDAN BS, BONNEAU RH, HENDRICKS RL: Stress-induced T cell deficiency leads to HSV-1 reactivation. J. Immunol. (2007) 179(1):322-328.
  • PADGETT DA, GLASER R: How stress influences the immune response. Trends Immunol. (2003) 24:444-448.
  • BIANCHI M, MENG C, IVASHKIV LB: Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. Proc. Natl. Acad. Sci. USA (2000) 97:9573-9578.
  • HU X, LI WP, MENG C, IVASHKIV LB: Inhibition of IFN-γ signaling by glucocorticoids. J. Immunol. (2003) 170:4833-4839.
  • RAY A, PREFONTAINE KE: Physical association and functional antagonism between the p65 subunit of transcription factor NF-α B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA (1994) 91:752-756.
  • AUPHAN N, DIDONATO JA, ROSETTE C, HELMBERG A, KARIN M: Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science (1995) 270:286-290.
  • JONAT C, RAHMSDORF HJ, PARK KK et al.: Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell (1990) 62:1189-1204.
  • WARGNIER A, LAFAURIE C, LEGROS-MAIDA S et al.: Down-regulation of human granzyme B expression by glucocorticoids. Dexamethasone inhibits binding to the Ikaros and AP-1 regulatory elements of the granzyme B promoter. J. Biol. Chem. (1998) 273:35326-35331.
  • COREY L, LANGENBERG AGM, ASHLEY R et al.: Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection – two randomized controlled trials. JAMA (1999) 282:331-340.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.